trending Market Intelligence /marketintelligence/en/news-insights/trending/cdPjRHDtLqWKvQggQ2_L-A2 content esgSubNav
In This List

Mesoblast raises US$40M in placement

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Mesoblast raises US$40M in placement

Mesoblast Ltd. completed a fully underwritten institutional placement of 26.25 million new shares, priced at A$2 per share, to global institutional investors.

The company plans to use the proceeds of about US$40 million for its ongoing phase 3 clinical programs including chronic heart failure, and for manufacturing requirements related to product commercialization.

Bell Potter Securities Ltd. acted as lead manager and underwriter to the placement.

As of March 24, US$1 was equivalent to A$1.31.